Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 66, n° 4
pages 689-690 (avril 2012)
Doi : 10.1016/j.jaad.2011.10.034
Notes & Comments

Methotrexate and psoriasis: Consensus conference

Robert E. Kalb, MD a, , Bruce Strober, MD, PhD b, Gerald Weinstein, MD c, Mark Lebwohl, MD d
a Department of Dermatology, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, NY 
b Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut 
c Department of Dermatology, University of California at Irvine, Irvine, California 
d Department of Dermatology, Mount Sinai School of Medicine, New York, NY 

Correspondence to: Robert E. Kalb, MD, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, 325 Essjay Rd, Suite 210, Buffalo, NY 14221

 Funding sources: None.
 Disclosure: Dr Kalb has served as an investigator for Abbott, Amgen, Astellas, and Centocor; a consultant for Abbott, Amgen, Jannsen, LEO Pharmaceuticals, and Stiefel; and received lecture fees from Abbott, Amgen, Jannsen, Galderma, and Stiefel. Dr Strober has been a consultant, investigator, and served on the advisory boards for Amgen, Abbott, Jannsen, Celgene, Pfizer, and Novartis and received lecture fees from Abbott. Dr Weinstein declared no conflicts of interest. Dr Lebwohl has served as a consultant for AbGenomics, Allos, Amgen, Can-Fite BioPharma, DermaGenoma, DermiPsor, Glenmark Pharmaceuticals, Helix BioMedix, Jannsen, LEO Pharmaceuticals, Novartis, Pfizer, Ranbaxy, Stiefel, and Valeant; and served as an investigator for Clinuvel, Celgene, LEO Pharmaceuticals, Can-Fite BioPharma, and Jannsen.

Top of the page

© 2011  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline